Evidence map›Paper›PMID 26678884›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.

Xiao-Dan Luo, Shao-Jiang Yang, Jia-Ni Wang, Li Tan, Dan Liu, Ya-Ya Wang, Run-Hui Zheng, Xiao-Hong Wu, Li-Hua Xu, Huo Tan

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. CTSB Knockdown Inhibits Proliferation and Tumorigenesis in HL-60 Cells.International journal of medical sciences · 2021
    Observational
  5. Article
  6. INHBA knockdown inhibits proliferation and invasion of nasopharyngeal carcinoma SUNE1 cells in vitro.International journal of clinical and experimental pathology · 2020
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xiao-Dan LuoDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China.
Shao-Jiang YangDepartment of Hematology, The First People's Hospital of Foshan, Foshan, 528000, China.
Jia-Ni WangBreast Cancer Center, The third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Li TanDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China.
Dan LiuDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China.
Ya-Ya WangDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China.
Run-Hui ZhengDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China.
Xiao-Hong WuDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China.
Li-Hua XuDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China. xlhua325@126.com.
Huo TanDepartment of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, People's Republic of China. tanhuo2008@126.com.
First Affiliated Hospital of Guangzhou Medical University · CNGuangzhou Medical University · CNFirst People's Hospital of Foshan · CNThird Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Special AT-rich sequence-binding protein-1 (SATB1) is critical for genome organizer that reprograms chromatin organization and transcription profiles, and associated with tumor growth and metastasis in several cancer types. Many studies suggest that SATB1 overexpression is an indicator of poor prognosis in various cancers, such as breast cancer, malignant cutaneous melanoma, and liver cancer. However, their expression patterns and function values for adult T cell leukemia (ATL) are still largely unknown. The aim of this study is to examine the levels of SATB1 in ATL and to explore its function and mechanisms in Jurkat cell line. Here, we reported that SATB1 expressions were decreased in ATL cells (p < 0.001) compared with normal controls. Knockdown of SATB1 expression significantly enhanced invasion of Jurkat cell in vitro. Furthermore, knockdown of SATB1 gene enhances β-catenin nuclear accumulation and transcriptional activity and thus may increase the invasiveness of Jurkat cell through the activation of Wnt/β-catenin signaling pathway in vitro.

Indexed as

Gene Expression Regulation, NeoplasticAdultCell Line, TumorDown-RegulationGene Expression ProfilingHumansJurkat CellsLeukemia-Lymphoma, Adult T-CellMatrix Attachment Region Binding ProteinsNeoplasm InvasivenessNeoplasm ProteinsRNA InterferenceRNA, MessengerRNA, NeoplasmRNA, Small InterferingWnt Signaling PathwayMatrix Attachment Region Binding ProteinsNeoplasm ProteinsRNA, MessengerRNA, NeoplasmRNA, Small InterferingSATB1 protein, humanATLInvasionSATB1β-Catenin

Identifiers

PMID26678884
OpenAlexW2219228457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.